Combined Rifampicin and Ursodeoxycholic Acid Treatment Does Not Amplify Rifampicin Effects on Hepatic Detoxification and Transport Systems in Humans

Publisher： Karger

E-ISSN： 1421-9867|86|3|244-249

ISSN： 0012-2823

Source： Digestion, Vol.86, Iss.3, 2012-09, pp. : 244-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and Psoriasis

By Itoh Susumu   Kanazuka Azuma   Akimoto Takahide  

Digestive Diseases and Sciences, Vol. 48, Iss. 11, 2003-11 ,pp. : 2182-2186

Springer Publishing Company

Access to resources Recommend Favorite

Does Ursodeoxycholic Acid Change the Proliferation of the Colorectal Mucosa?

By  

Digestion, Vol. 68, Iss. 4, 2004-02 ,pp. : 209-216

Karger

Access to resources Recommend Favorite

Effects of Ursodeoxycholic Acid on Splanchnic and Systemic Hemodynamics

By  

Digestion, Vol. 61, Iss. 2, 2000-02 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 85-88

Karger

Access to resources Recommend Favorite

Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients

By  

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 117-118

Karger

Access to resources Recommend Favorite